Cargando…
Novel oral-targeted therapies for mucosal healing in ulcerative colitis
Ulcerative colitis (UC), a chronic, relapsing, remitting disease of the colon and rectum, is characterized by inflammatory ulceration of the mucosa. Current UC therapy relies on controlling acute episodes and preventing relapse. To predict modifications in the natural course of UC, mucosal healing (...
Autores principales: | Antonelli, Elisabetta, Villanacci, Vincenzo, Bassotti, Gabrio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305528/ https://www.ncbi.nlm.nih.gov/pubmed/30598577 http://dx.doi.org/10.3748/wjg.v24.i47.5322 |
Ejemplares similares
-
Papillary thyroid cancer and ulcerative colitis
por: Casella, Giovanni, et al.
Publicado: (2013) -
Successful twin pregnancy in a patient with ulcerative colitis using azathoprine during conception
por: Casella, Giovanni, et al.
Publicado: (2011) -
Usefulness of Different Pathological Scores to Assess Healing of the Mucosa in Inflammatory Bowel Diseases: A Real Life Study
por: Villanacci, Vincenzo, et al.
Publicado: (2017) -
Mucosal tissue transglutaminase expression in celiac disease
por: Villanacci, Vincenzo, et al.
Publicado: (2009) -
Gaseous metabolites as therapeutic targets in ulcerative colitis
por: Yao, Chu K, et al.
Publicado: (2023)